Regen BioPharma Inc (RGBP) EBIT (2013 - 2026)
Regen BioPharma (RGBP) reported EBIT of -$637,785 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$40,756 a year earlier.
Regen BioPharma Inc (RGBP) EBIT (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regen BioPharma's EBIT came in at -$1.35 million; for FY2025 (ended Sep 30, 2025), it came in at -$338,540.
- By fiscal year, EBIT came in at -$417,221 in FY2024, -$686,950 in FY2023, -$339,605 in FY2022 and -$200,771 in FY2021.
- The fiscal Q3 2026 figure ranks as the lowest quarterly EBIT since fiscal Q1 2018.
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -637,785.00 |
| Dec 31, 2025 | -551,624.00 |
| Sep 30, 2025 | -123,055.00 |
| Jun 30, 2025 | -40,756.00 |
| Mar 31, 2025 | -113,349.00 |
| Dec 31, 2024 | -61,378.00 |
| Sep 30, 2024 | -85,402.00 |
| Jun 30, 2024 | -107,966.00 |
| Mar 31, 2024 | -101,071.00 |
| Dec 31, 2023 | -122,782.00 |
| Sep 30, 2023 | -59,087.00 |
| Jun 30, 2023 | -85,155.00 |
| Mar 31, 2023 | -78,842.00 |
| Dec 31, 2022 | -463,867.00 |
| Sep 30, 2022 | -97,779.00 |
| Jun 30, 2022 | -58,910.00 |
| Mar 31, 2022 | -76,494.00 |
| Dec 31, 2021 | -106,422.00 |
| Sep 30, 2021 | -126,826.00 |
| Jun 30, 2021 | -42,491.00 |
Regen BioPharma Inc EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RGBP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RGBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RGBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();